We measured haemodynamic effects and uptake of enjlurane in patients undergoing cardiac surgery utilizing a standard anaesthetic technique of fentanyl 15 mcglkg nitrous oxide 50%lenjlurane 1%. We divided 22 patients preoperatively into two groups according to standard criteria: good and poor myocardial function. Regression lines could be drawn illustrating the relationship of cardiac output and uptake (at 1 minute: r = -0.56, P < 0.01; at 5 minutes: r = -0.43. P < 0.05; at 30 minutes: r= -0.31. P= 0.08). Although patients with poor myocardialfunction had decreased uptake of enjlurance (approximately 10-20%). this did not reach statistical significance. Fentanyl/nitrous oxidelenjlurane anaesthesia provided stable haemodynamics. even in patients with poor myocardial function. Both groups had a shunt fraction of approximately 10% and an arterial: end-tidal carbon dioxide difference of approximately 3-4 mmHg.
brain and heart concentrations, leading to a more rapid induction, a greater depth of anaesthesia and potential adverse haemodynamic effects. A vicious circle can occur, where the uptake of the volatile agent is potentiated by the low cardiac output, and the cardiac output is further impaired by the greater concentration of volatile agent. The magnitude of this effect is related to blood solubility (greater solubility: greater effect). I In a recent study, Dwyer et al. lo described uptake in an elderly group of healthy patients. Using a similar measurement technique to our study, they found a slower rate of rise of isoflurane in the elderly group at fifteen minutes. They suggested this may have been due to ventilation-perfusion inequality, increased functional residual capacity, greater solubility of anaesthetics in the vessel-rich and muscle groups of tissues and increased body fat. This was a healthy group of patients and their myocardial function was presumed to be normal.
Patients undergoing cardiac surgery are frequently elderly and have impaired myocardial function. Controlled myocardial depression and afterload reduction may be beneficial because of the oxygen supply:demand ratio, [11] [12] [13] [14] though choice of anaesthetic technique appears to have little effect on outcome. 15.16 However, the use of volatile anaesthetic agents minimizes the risk of awareness under anaesthesia (cardiac surgery having a particularly high incidence),17.18 results in a more rapid ventilatory recovery,19 and avoids muscle rigidity at induction. 2o Compared with halothane, enflurane results in less myocardial depression and fewer arrhythmias,21 and a lower incidence of hepatitis. 22 Unlike enflurane, isoflurane has been implicated as a cause of the coronary steal phenomenon. 12.14.23.24 Thus enflurane, combined with moderate-dose fentanyl, has become a popular technique for cardiac anaesthesia.
The aim of this study was to compare uptake of enflurane in patients with good versus poor myocardial function (as classified at the preoperative visit), and to measure the haemodynamic effects of fentanyl/nitrous oxide/ enflurane anaesthesia in these patients.
MATERIALS AND METHODS

Patient selection
This study was approved by the Royal Perth Hospital Ethics Committee. After full explanation, informed consent was obtained from twenty-two patients who were scheduled for elective cardiac surgery. They were allocated to one of two groups following preoperative assessment -good or poor myocardial function (Table I) .
Patients were excluded if they had valvular stenosis, a known significant arteriovenous shunt, or gross underlying lung disease.
Clinical management
All patients received the same anaesthetic technique. The investigators were not directly responsible for the administration of anaesthesia; thus the patients were in the care of individual cardiac anaesthetists. Premedication consisted of oral lorazepam 3.0 mg, intramuscular morphine *NYHA: New York Heart Association classification 5-10 mg and droperidol 5-10 mg, with nitroglycerin applied transdermally and oxygen used at the discretion of the anaesthetist. When the patient arrived in the induction room, an electrocardiograph was applied and oxygen was continued via a PVC mask. All intravascular cannulations (venous, arterial, pulmonary arterial) were performed before induction, using increments of intravenous fentanyl if required. The patients were pre-oxygenated for five minutes, while cardiac output was measured. Anaesthesia was induced with intravenous fentanyl 15 mcg/kg and pancuronium 0.12 mg/kg. The patients were ventilated with a non-rebreathing circuit using a fresh gas flow of 12 litres/minute with inspired concentrations of 50% oxygen, 49% nitrous oxide and 1% enflurane; these values were confirmed with the Capnomac Ultima machine (Datex Instrumentarium Corp., Helsinki, Finland). Ventilation was adjusted to an end-tidal carbon dioxide of 32 mmHg. Following intubation ventilation was controlled with a tidal volume of 10 ml/kg, adjusting respiratory rate to maintain an end-tidal carbon dioxide of 32 mmHg. Systolic blood pressure was maintained above 90 mmHg using fluids (if PCWP < 10 mmHg) or increments of phenylephrine. No effort was made to control fluid administration.
If any patient required interventions outside the trial protocol, then the trial was abandoned.
Measurement technique
Nitrous oxide, carbon dioxide and enflurane concentrations were measured using the Capnomac Ultima gas analyser (Datex Instrumentarium Corp., Helsinki, Finland). This machine uses the infra-red absorption technique, sidestreamsampling gas from the anaesthetic circuit at a rate of 200 mllmin. Compared to the 'gold standard' of gas chromatography, earlier models have been shown to have excellent accuracy, linearity, stability (over six weeks), with a rapid response time (5-95% = 840 msec) (25) (26) (27) . The Capnomac Ultima was calibrated at weekly intervals according to the manufacturer's instructions. The Enfluratec vaporizer (Abbott Aust. Pty. Ltd., Sydney, Aust.) was adjusted to give an inspired concentration of enflurane of I % according to the Capnomac Ultima. A soft nasopharyngeal catheter was inserted following induction, before ventilation, to sample end-tidal gas before intubation. Following intubation, the gas samples were taken from an adaptor between the endotracheal tube and the catheter mount. Endtidal values of enflurane were recorded at I, 2, 3, 4, 5, 7, 10, 15, 20, 25 and 30 minutes. The endtidal:inspired ratio was used as an index of uptake. 3 . 10 ,28
Haemodynamic indices were recorded before induction at five-minute intervals for the period of the study. Cardiac output was measured using the thermodilution technique (manual injection, icecold saline 10 ml, at end-expiration); three measurements (within 10% of each other) were averaged. Cardiac index, systemic vascular resistance index and pulmonary vascular resistance index were calculated using the Sirecust 1280 cardiac index monitor (Siemans Medical Electronics Inc., U.S.A.). Arterial and mixed venous blood samples were taken at ten minutes to calculate per cent shunt 29 and arterial:end-tidal carbon dioxide difference. We did this to control for potential differences in pulmonary factors affecting uptake or measurement of alveolar enflurane concentration. Nasopharyngeal temperature was recorded at 10 and 30 minutes. The total dose of phenylephrine required to maintain arterial pressure was also recorded.
scheduled for coronary bypass grafting, with two patients in the good ventricle group also having a mitral valve replacement ( Table 2) . No trial was abandoned during the study period.
Statistics
Comparisons were made between the two groups. Data were analysed on an Amstrad 2386/65 computer, using the Statistical Package for Social Sciences V3.0. Nonparametric data was analysed using Mann-Whitney u test, parametric data was analysed using unpaired Student's t test. Confidence intervals were calculated where appropriate. Further analysis of the relationship between uptake and cardiac output was achieved with calculation of Pearson correlation coefficients(r) and regression lines at 1, 5 and 30 minutes (the preinduction cardiac output was used as the one-minute value). A P value > 0.05 was considered statistically not significant.
The haemodynamic effects were similar in the two groups (Table 3 and Figure 1) . Although there was a lower cardiac index in the poor ventricle group, this did not reach statistical significance at preinduction, 95% confidence interval (Cl) for the difference: -0.14 to 0.88, P = NS; at 5 minutes 95% Cl: -0.27 to 0.55, P= NS; or at 30 minutes, 95% Cl: -0.17 to 0.63, P = NS. The mean pulmonary artery pressure was higher in the poor ventricle group, though only statistically significant at 10 (P < 0.001) and 20 (P < 0.01) minutes.
There was no difference with temperature, either absolute or relative change. Both groups had a shunt fraction of approximately 10%. The arterial:end-tidal C02 difference, though statistically significant (P < 0.001), was of minimal clinical significance, with the median value being 3.0 mmHg for the good ventricle group (range: RESULTS There were eleven patients in each of the two groups included in the study. All patients were P<0.05).
The ratio of end-tidal:inspired concentration of enflurane did not differ significantly between the two groups during the study period ( Figure 2) . However, at all time intervals, there was a tendency for more rapid uptake of enflurane in the good ventricle group (and thus lower end-tidal concentrations). At five minutes the values were 0.58 (good ventricle) and 0.66 (poor ventricle), 95% Cl for the difference: -0.19 to 0.35, P = NS; at 10 minutes were 0.64 (good ventricle) and 0.79 (poor ventricle) 95% Cl: -0.10 to 0.24, P = NS; and at 30 minutes were 0.70 (good ventricle) and 0.76 (poor ventricle), 95% Cl: -0.07 to 0.19, P = NS.
As expected, there was a correlation of cardiac output with end-tidal:inspired ratio; at 1 min: r= -0.56,P< 0.01); 5 min: r = -0.43,P< 0.05); 30 min: r=-0.31, P=0.08 (Figure 3 ).
DISCUSSION
The primary aims of this study were to compare the rates of uptake of enflurane in patients with good versus poor myocardial function, and to compare the haemodynamic effects in these two groups. Such dichotomous classification is artificial as myocardial function lies on a continuum; nevertheless, our routine preoperative assessment aims to divide patients into either group as a guide to anaesthetic technique. 30 Myocardial function does not necessarily equate with cardiac output, which is dependent on many factors, including preload, afterload, heart rate and contractility. In this study we altered these factors by administering fluid, anaesthetic agents and a vasoconstrictor (phenylephrine). This was obviously necessary to provide proper care of the patients. Naturally uptake of enflurane is dependent on actual cardiac output, which did not differ significantly between the two groups. A larger study (we calculate approximately 100 patients for power > 0.8) would be required to show a statistically significant result; alternatively, more stringent criteria could be used to further separate the two groups. Nevertheless, a trend was demonstrated where patients with poor myocardial function had slower uptake of enflurane, and thus a more rapid rise in end-tidal concentration. This could also be seen with a correlation between uptake and cardiac output. Hence, the theoretical effect of cardiac output on uptake can be demonstrated, but this effect is of minimal significance in routine anaesthetic practice. Haemodynamic effects were also remarkably similar, although patients with poor myocardial function required more phenylephrine to maintain stability. However, the total doses used were small (average: 139 and 245 mcg for the two groups). Kemmotsou et af.3' found that enflurane caused by a greater degree of myocardial depression in the failing heart compared to normal (using isolated papillary muscle from cats with experimental heart failure). Rydvall et a/Y found that 1 MAC enflurane/nitrous oxide anaesthesia caused a significant decrease in blood pressure (approx. 65%) and cardiac output (approx. 40%), with some evidence of myocardial ischaemia (presumably due to decreased coronary perfusion pressure and perhaps coronary redistribution). In our study, where we placed no restriction on fluid administration or use of phenylephrine, the technique of fentanyl/nitrous oxide/enflurane anaesthesia provided stable haemodynamics, even for patients with poor myocardial function.
End-tidal carbon dioxide monitoring is becoming' increasingly popular. Despite the potential inaccuracies of predicting arterial carbon dioxide, our study demonstrates a consistent difference of approximately 3-4 mmHg (range: 0-8 mmHg). Hence we suggest aiming for an end-tidal carbon dioxide of 32-36 mmHg in patients undergoing cardiac surgery, but would still recommend arterial blood gas sampling to ensure normocarbia.
Rapid measurement of inspired/expired gases enhanced appreciation of gas exchange, metabolism, uptake of anaesthetic agent and cardiac function. It was felt that this added to the quality of monitored care in our patients.
